Optical Coherence Tomography Evaluation of Late Strut Coverage Patterns Between First-Generation Drug-Eluting Stents and Everolimus-Eluting Stent

被引:7
|
作者
Toledano Delgado, Francisco Javier [1 ]
Pan Alvarez-Ossorio, Manuel [1 ]
de Lezo Cruz-Conde, Jose Suarez [1 ]
Mazuelos Bellido, Francisco [1 ]
Romero Moreno, Miguel Angel [1 ]
Medina Fernandez-Aceytuno, Alfonso [2 ]
de Lezo Herreros de Tejada, Javier Suarez [1 ]
Ojeda Pineda, Soledad [1 ]
Segura Saint-Gerons, Jose Maria [1 ]
Pavlovic, Djordje [1 ]
机构
[1] Hosp Reina Sofia, Dept Cardiol, Cordoba 14004, Spain
[2] Dr Negrin Hosp, Dept Cardiol, Las Palmas Gran Canaria, Spain
关键词
stent structure; neointimal coverage; drug delivery; malapposed struts; uncovered struts; optical coherence tomography; CORONARY STENT; THROMBOSIS; TRIALS; IMPLANTATION; METAANALYSIS; APPOSITION; SYSTEM;
D O I
10.1002/ccd.25235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo compare strut coverage patterns between everolimus-eluting stent (EES) and first-generation drug-eluting stents (DES) at more than 12 months after successful implantation, using optical coherence tomography (OCT). BackgroundNo sufficient OCT data has been reported comparing late strut coverage patterns between EES and first-generation DES. The favorable late results after EES implantation could be related to lower rates of uncovered and malapposed struts. MethodsA total of 66 DES (21 EES, 23 SES, and 22 PES) that were implanted at least 1 year in advance in 40 patients and met good late angiographic results were evaluated by OCT. The percentage of uncovered and malapposed struts, calculated as the ratio of uncovered or malapposed struts to total struts in all cross-sectional images per stent, was compared among the three groups. ResultsA total of 35,061 struts were analyzed: 11,967 from EES, 11,855 from SES, and 11m239 from PES. The average tissue coverage thickness of the struts per stent was greater in EES than in SES and PES (10940 mu m vs. 72 +/- 27 mu m and 83 +/- 26 mu m, respectively; P=0.001). The percentage of uncovered struts (1.9 +/- 4.1% in EES vs. 11.6 +/- 12.7% in SES, P=0.01 and vs. 7.1 +/- 5.2% in PES, P<0.001) and malapposed struts (0.1 +/- 0.3% in EES vs. 1.8 +/- 3.5% in SES, P=0.01 and vs. 3.5 +/- 5.1% in PES, P=0.02) was much lower in EES than in first-generation DES, with no significant differences between SES and PES. ConclusionsLate strut coverage patterns are not similar between EES and first-generation DES. EES showed a lower percentage of uncovered and malapposed struts. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:720 / 726
页数:7
相关论文
共 50 条
  • [1] First-Generation Drug-Eluting Stent Versus Everolimus-Eluting Stents to Coronary Intervention in Dialysis Patients
    Sakakibara, Takashi
    Ishii, Hideki
    Yoneda, Kouhei
    Kawashima, Kazuhiro
    Kawamura, Yoshihiro
    Kamoi, Daisuke
    Aoyama, Toru
    Furuhashi, Kyuuichi
    Kumada, Yoshitake
    Takahashi, Hiroshi
    Tanaka, Miho
    Murohara, Toyoaki
    [J]. CIRCULATION, 2011, 124 (21)
  • [2] Neointimal coverage on everolimus-eluting stent struts crossing side-branch vessels compared with first generation drug-eluting stents: an optical coherence tomography analysis
    Nasu, K.
    Kurita, T.
    Ko, E.
    Yokota, D.
    Ito, T.
    Habara, M.
    Kinoshita, Y.
    Terashima, M.
    Suzuki, T.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 403 - 403
  • [3] Optical coherence tomography assessment of strut coverage of a fully biodegradable Everolimus-eluting stent
    Kukreja, N.
    Regar, E.
    De Winter, S.
    Bruining, N.
    Sianos, G.
    Serruys, P. W.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 263 - 263
  • [4] Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial)
    Kubo, Takashi
    Akasaka, Takashi
    Kozuma, Ken
    Kimura, Kazuo
    Kawamura, Masaki
    Sumiyoshi, Tetsuya
    Ino, Yasushi
    Morino, Yoshihiro
    Tanabe, Kengo
    Kadota, Kazushige
    Kimura, Takeshi
    [J]. EUROINTERVENTION, 2015, 11 (05) : 564 - 571
  • [5] Everolimus-eluting Stents Demonstrate Better Vascular Healing and Function Compared to First-generation Drug-eluting Stents
    Mitsutake, Yoshiaki
    Ueno, Takafumi
    Yokoyama, Shinji
    Awata, Masaki
    Sasaki, Ken-ichiro
    Toyama, Yasuyuki
    Koiwaya, Hiroshi
    Nakayoshi, Takaharu
    Itaya, Naoki
    Chibana, Hidetoshi
    Imaizumi, Tsutomu
    [J]. CIRCULATION, 2011, 124 (21)
  • [6] Comparison of strut-vessel distance of acute incomplete strut apposition between everolimus-eluting stent and 1st-generation drug-eluting stent: optical coherence tomography analysis
    Inoue, T.
    Shinke, T.
    Otake, H.
    Nakagawa, M.
    Hariki, H.
    Osue, T.
    Nishio, R.
    Iwasaki, M.
    Taniguchi, Y.
    Hirata, K.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 549 - 550
  • [7] Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice
    Waksman, Ron
    Barbash, Israel M.
    Dvir, Danny
    Torguson, Rebecca
    Ben-Dor, Itsik
    Maluenda, Gabriel
    Xue, Zhenyi
    Satler, Lowell F.
    Suddath, William O.
    Kent, Kenneth M.
    Pichard, Augusto D.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (09): : 1288 - 1294
  • [8] Second-Generation Everolimus-Eluting Stents Compared to First-Generation Drug-Eluting Stents in Patients Treated for Multivessel Disease
    Minha, Sa'ar
    Barbash, Israel M.
    Dvir, Danny
    Loh, Joshua P.
    Badr, Salem
    Kitabata, Hironori
    Pendyala, Lakshmana K.
    Pichard, Augusto D.
    Torguson, Rebecca
    Waksman, Ron
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2013, 26 (06) : 561 - 569
  • [9] Safety and Efficacy Outcomes of Overlapping Second-Generation Everolimus-Eluting Stents Versus First-Generation Drug-Eluting Stents
    Kitabata, Hironori
    Loh, Joshua P.
    Pendyala, Lakshmana K.
    Badr, Salem
    Dvir, Danny
    Barbash, Israel M.
    Minha, Sa'ar
    Torguson, Rebecca
    Chen, Fang
    Satler, Lowell F.
    Suddath, William O.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Waksman, Ron
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (08): : 1093 - 1098
  • [10] SECOND-GENERATION EVEROLIMUS-ELUTING STENTS VERSUS FIRST-GENERATION DRUG-ELUTING STENTS FOR PATIENTS TREATED FOR MULTIVESSEL DISEASE
    Minha, Sa'ar
    Barbash, Israel
    Dvir, Danny
    Ben-Dor, Itsik
    Loh, Joshua
    Badr, Salem
    Pendyala, Lakshmana
    Kitabata, Hironori
    Satler, Lowell
    Pichard, Augusto
    Suddath, William
    Kent, Kenneth
    Torguson, Rebecca
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1705 - E1705